share_log

復宏漢霖:自願公告 - HLX6018在健康受試者中開展的1期臨床研究於中國境內完成首例受試者給藥

HENLIUS: VOLUNTARY ANNOUNCEMENT - THE FIRST SUBJECT HAS BEEN DOSED IN A PHASE 1 CLINICAL STUDY IN HEALTHY SUBJECTS OF HLX6018 IN MAINLAND CHINA

Hong Kong Stock Exchange ·  Apr 23 04:49
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more